Anthropic’s (ANT) IPO Is Six Times Oversubscribed as Investor Demand Builds

Anthropic's (ANT) IPO is six times oversubscribed, with plans to sell 825 million Class A shares at $70-$78 each, potentially raising $64.35 billion. Goldman Sachs (GS) and Morgan Stanley (MS) are underwriters. Trading is expected to start on Nasdaq on Nov. 19, with a valuation of around $1.5 trillion. 20% of shares are reserved for retail investors, double the typical allocation.

Original reporting
Published Nov 13, 2026, 7:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 7:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefIPO
Primary signal
$ANT
Bullish
high confidence
Mentioned
$ANT
Relevance
8/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$ANTBullishHigh
01

Why it matters

The six‑fold oversubscription signals strong demand, likely resulting in a strong opening price, but limited retail allocation may cause disappointment among smaller investors.

02

Market read

First‑report of a massive AI IPO with strong demand; likely to move markets on debut.

03

What to watch

Potential regulatory scrutiny of AI firms and the broader market's appetite for high‑valuation tech listings could temper upside.

Relevance 8/10Novelty 8/10Timing: pre‑market ahead of Nov 19 debut

Background

Anthropic, an AI startup, is preparing a Nasdaq IPO with a projected $1.5 trillion valuation, a rare size for a debut.

Company-level read

Ticker impact

$ANTBullishHigh confidence
Context

Anthropic's IPO is reported to be six‑times oversubscribed, with 825 million shares priced at $70‑$78 and trading to begin on Nasdaq.

Expected impact

upward pressure as investors scramble for limited allocations

Evidence & confidence

Oversubscription of this magnitude is rare and indicates market appetite; limited retail allocation may intensify buying pressure.

Market effects

Highlights continued investor enthusiasm for AI‑focused companies, potentially boosting related AI hardware and software stocks.

U.S. tech market may see a lift on the day of the debut as the IPO draws attention.

Large AI IPO adds to global AI sector momentum, influencing overseas AI‑related equities.

Counterpoint

If allocation remains tight, retail investors could be sidelined, and the hype may fade, leading to a post‑IPO sell‑off.

Key entities

  • Anthropic

    AI startup planning a Nasdaq IPO.

  • Goldman Sachs

    Lead underwriter for the Anthropic IPO.

  • Morgan Stanley

    Co‑lead underwriter for the Anthropic IPO.

Related articles

$ANTHighAI 9/10

Anthropic CEO sells investors on safety, 'no jerks' culture

Anthropic CEO Dario Amodei emphasized AI safety and a strict hiring culture to investors ahead of the company's IPO, targeting enterprise customers. The company set a price range of $70-$78 per share, aiming to raise up to $64.4 billion and value it at about $1.4 trillion. Amodei predicted new markets from AI advancements and stressed the importance of talent and culture.

$ANTMedAI 8/10

Anthropic Reports Complex Financial Situation Heading Up To IPO

Anthropic, an AI company, reported $16B revenue and $80B loss in its S-1 filing, primarily due to convertible notes held by Amazon. The company holds $132B in cash and plans an IPO projected to raise $100B+, with a potential valuation of up to $2T. Amazon's notes may convert into shares, diluting other shareholders. Traders speculate on its IPO valuation, with odds shifting towards lower values.

$ANTMedAI 8/10

Anthropic IPO shuts out Chinese investors amid US-China tensions

Anthropic's $1.4T IPO excludes Chinese investors due to US ITAR restrictions, per Bloomberg. Banks refuse orders from mainland China and Hong Kong. Investors explore offshore structures. Demand is high, with orders at 6x supply. The company aims to raise $90.4B. Trading starts Nov. 19 on Nasdaq under ANT. The company faces a legal dispute with the Pentagon.